BIOJECT MEDICAL TECHNOLOGIES INC (BJCT) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 138 transactions totaling $173.0K, demonstrating a bullish sentiment with $173.0K in net insider flow. The most recent transaction on Apr 30, 2014 involved a transaction of 547,220 shares valued at $71.1K.
No significant insider buying has been recorded for BJCT in the recent period.
No significant insider selling has been recorded for BJCT in the recent period.
Based on recent SEC filings, insider sentiment for BJCT is bullish with an Insider Alignment Score of 100/100 and a net flow of $173.0K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at BIOJECT MEDICAL TECHNOLOGIES INC (BJCT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading BJCT stock, having executed 138 transactions in the past 90 days. The most active insider is Edward L. Flynn (Executive), who has made 12 transactions totaling $719.1K.
Get notified when executives and directors at BJCT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Apr 30, 2014 | L. Flynn Edward | Executive | Conversion | 547,220 | $0.13 | $71.1K | |
| Apr 30, 2014 | L. Flynn Edward | Executive | Conversion | 784,200 | $0.75 | $588.1K | Large |
| Apr 30, 2014 | S. Tierney David | Executive | Conversion | 78,400 | $0.75 | $58.8K | |
| Apr 30, 2014 | Farrell Christine | Executive | Conversion | 11,700 | $0.75 | $8.8K | |
| Apr 30, 2014 | Stout Richard | Executive | Conversion | 11,700 | $0.75 | $8.8K | |
| Apr 30, 2014 | C. Gale James | Executive | Conversion | 1,770,073 | $N/A | $0 | |
| Apr 30, 2014 | C. Gale James | Executive | Conversion | 207,255 | $N/A | $0 | |
| Apr 30, 2014 | C. Gale James | Executive | Conversion | 8,290,002 | $N/A | $0 | |
| Apr 30, 2014 | C. Gale James | Executive | Conversion | 1,820,483 | $N/A | $0 | |
| Apr 30, 2014 | C. Gale James | Executive | Conversion | 656,306 | $N/A | $0 | |
| Apr 30, 2014 | C. Gale James | Executive | Conversion | 1,482,067 | $N/A | $0 | |
| Apr 30, 2014 | C. Gale James | Executive | Conversion | 325,908 | $N/A | $0 | |
| Apr 30, 2014 | C. Gale James | Executive | Conversion | 316,884 | $N/A | $0 | |
| Dec 31, 2011 | Farrell Christine | Executive | Option Exercise | 25,000 | $N/A | $0 | |
| Dec 31, 2011 | Stout Richard | Executive | Option Exercise | 25,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Conversion(C) | 17 | $875.7K | 68.1% |
Purchase(P) | 19 | $173.0K | 13.4% |
Payment(F) | 10 | $136.4K | 10.6% |
Award(A) | 9 | $101.0K | 7.9% |
Exercise(M) | 83 | $0 | 0.0% |
Insiders at BIOJECT MEDICAL TECHNOLOGIES INC are accumulating shares at an accelerated pace. With 15 insiders making 138 transactions totaling $173.0K in purchases versus $0 in sales, the net buying activity of $173.0K signals strong executive confidence. Edward L. Flynn (Executive) leads the buying activity with $719.1K in transactions across all time.